⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HCWB News
HCW Biologics Inc. Common Stock
Form 8-K
sec.gov
HCWB
HCW Biologics Announces 1-for-6 Reverse Stock Split Effective on June 30, 2026
globenewswire.com
HCWB
Form 8-K
sec.gov
HCWB
HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata
globenewswire.com
HCWB
Form 8-K
sec.gov
HCWB
Form 8-K
sec.gov
HCWB
Form 8-K
sec.gov
HCWB
HCW Biologics Exercised Option to Regain Full Rights for Two Commercial-Ready Reagents from Wugen
globenewswire.com
HCWB
E.F. Hutton & Co. Serves as Sole Placement Agent on HCW Biologics Inc. $4.0 Million Private Placement
globenewswire.com
HCWB
This Emerging Biotech Wave Could Create the Next Monster Healthcare Winners
globenewswire.com
AKTX
NTHI
MTVA
HCWB